Free Trial

Novozymes A/S (OTCMKTS:NVZMY) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened

Novozymes A/S logo with Basic Materials background

Key Points

  • Shares of Novozymes A/S recently fell below their 200-day moving average, trading as low as $63.20, while the current price is $63.82.
  • Zacks Research downgraded Novozymes A/S from a "strong-buy" to a "hold" rating, impacting its overall consensus rating to "Moderate Buy."
  • The company announced a dividend of $0.1856 per share, with an ex-dividend date set for September 2nd, signaling a dividend yield of 88.0%.
  • MarketBeat previews top five stocks to own in October.

Shares of Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $65.54 and traded as low as $63.20. Novozymes A/S shares last traded at $63.82, with a volume of 45,208 shares.

Wall Street Analyst Weigh In

Separately, Zacks Research lowered Novozymes A/S from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 25th. Two investment analysts have rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy".

View Our Latest Stock Report on Novozymes A/S

Novozymes A/S Price Performance

The company has a current ratio of 1.75, a quick ratio of 1.07 and a debt-to-equity ratio of 0.28. The firm has a market cap of $29.89 billion, a PE ratio of 40.39, a price-to-earnings-growth ratio of 1.25 and a beta of 0.93. The stock has a 50 day simple moving average of $66.84 and a 200-day simple moving average of $65.54.

Novozymes A/S Cuts Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, September 11th. Stockholders of record on Wednesday, September 3rd will be given a dividend of $0.1856 per share. The ex-dividend date is Tuesday, September 2nd. This represents a dividend yield of 88.0%. Novozymes A/S's dividend payout ratio (DPR) is presently 23.42%.

About Novozymes A/S

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novozymes A/S Right Now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.